Market revenue in 2022 | USD 9,584.7 million |
Market revenue in 2030 | USD 20,582.1 million |
Growth rate | 10% (CAGR from 2022 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Enzymes |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Kits & Reagents, Enzymes |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.62% in 2022. Horizon Databook has segmented the North America molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the molecular biology enzymes, kits, and reagents market with the largest revenue share in 2019. Rising prevalence of cancer has led to an increase in NGS applications. This is expected to drive the demand for enzymes and reagents required in NGS.
In addition, initiatives such as Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT) program by National Human Genome Research Institute to screen infants for genetic diseases also boosts the adoption of sequencing technology in the region.
Furthermore, increasing prevalence of chronic and genetic disorders, which involve molecular diagnostics, is also contributing to the market growth. In February 2019, healthcare and research organizations from the U.S. and Canada launched a consortium for Medical Genome Initiative that focused on increasing the access to whole genome sequencing for genetic disease diagnosis.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This continent databook contains high-level insights into North America molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account